Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.

Stolbach LL, Begg CB, Hall T, Horton J.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):689-92.

PMID:
6454485
2.
3.

Practice and progress in kidney cancer: methodology for novel drug development.

Rini BI, Weinberg V, Small EJ.

J Urol. 2004 Jun;171(6 Pt 1):2115-21. Review.

PMID:
15126769
4.

The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma.

Kjaer M.

Cancer Treat Rev. 1988 Sep;15(3):195-209. Review. No abstract available.

PMID:
2974757
5.

Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.

Bukowski RM.

Semin Oncol. 2000 Apr;27(2):204-12. Review.

PMID:
10768599
6.
7.

Sorafenib for the treatment of advanced renal cell carcinoma.

Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, Liang C, Booth B, Chidambaram N, Morse D, Sridhara R, Garvey P, Justice R, Pazdur R.

Clin Cancer Res. 2006 Dec 15;12(24):7271-8. Review.

8.

The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review.

Schwallie PC.

Contraception. 1981 Apr;23(4):375-86. Review.

PMID:
6456130
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk